Articles by tag: pharmaceutical production pipeline
Latest
VuWall’s Security Features Utilize AV Over IP to Meet Workplace Security Demands
The significant shift in security demands has seen modest operation centers evolve into larger, more intricate spaces. This change isn’t just a nod to expansion but underscores the demand and importance of comprehensive security in modern businesses. Then enter AV over IP solutions, which replaces the old-fashioned bulky matrix switchers and provides a decentralized […]
GSX 2023: The Present And Future Of Cybersecurity Architecture With Johnson Controls
In today’s rapidly evolving technological landscape, the integration of security systems and cybersecurity architecture is paramount for businesses. Johnson Controls, one of the biggest security system integrators in North America, recognizes the challenges faced by organizations in ensuring the reliability and uptime of their security investments. With the rise of connected devices, cybersecurity threats have […]
FIS Podium
Designed in collaboration with CBP, Parabit FIS Podiums are intelligently designed to support touchless passenger processing and efficiently accommodate change over time – technology upgrades, the way passengers are processed, and the way people flow is managed.
Is It Time to Revamp the Drug Development Pipeline?
Keypoints: Pharmaceutical industry is under pressure to increase demand and productivity. Pharma manufacturers are also expected to reduce waste in the drug development pipeline. Translational research is to get an idea to translate in a way to benefit the patient. Commentary: The pharmaceutical industry is undergoing a series of rapid changes. These days, there […]
What Can the Pharma Industry Learn from Merck’s New Antiviral?
Merck is one of the first pharmaceutical companies to submit an antiviral candidate to the FDA for approval, signaling the beginning of a new phase of mass production of COVID treatment drugs. For Merck’s oral antiviral, molnupiravir, its optimistic success can be largely credited to its federal funding. Work on the related compound was […]
With Merck’s COVID Antiviral Announcement, Can the Pharma Pipeline Build Treatment Momentum?
At the start of the month, pharmaceutical company Merck dropped big news: It has developed a COVID antiviral drug that would cut hospitalization and mortality risks by 50%. In the drug’s study, patients taking the placebo pill saw 14% hospitalization rate and eight deaths, while the trial group with Merck’s drug had only 7% […]